These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8354119)

  • 1. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.
    Hedley DW; Clark GM; Cornelisse CJ; Killander D; Kute T; Merkel D
    Cytometry; 1993; 14(5):482-5. PubMed ID: 8354119
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.
    Wheeless LL; Badalament RA; de Vere White RW; Fradet Y; Tribukait B
    Cytometry; 1993; 14(5):478-81. PubMed ID: 8354118
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer.
    Bauer KD; Bagwell CB; Giaretti W; Melamed M; Zarbo RJ; Witzig TE; Rabinovitch PS
    Cytometry; 1993; 14(5):486-91. PubMed ID: 8354120
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus review of the clinical utility of DNA content cytometry in prostate cancer.
    Shankey TV; Kallioniemi OP; Koslowski JM; Lieber ML; Mayall BH; Miller G; Smith GJ
    Cytometry; 1993; 14(5):497-500. PubMed ID: 8354122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
    Berho M; Viciana AL; Poppiti RJ; Ruiz P
    J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.
    Hedley DW; Clark GM; Cornelisse CJ; Killander D; Kute T; Merkel D
    Breast Cancer Res Treat; 1993 Oct; 28(1):55-9. PubMed ID: 8123870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.
    Duque RE; Andreeff M; Braylan RC; Diamond LW; Peiper SC
    Cytometry; 1993; 14(5):492-6. PubMed ID: 8354121
    [No Abstract]   [Full Text] [Related]  

  • 9. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
    Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
    Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoploidy defines patients with poor prognosis in breast cancer.
    Chavez-Uribe E; Cameselle-Teijeiro J; Viñuela JE; Castro-Piñeiro C; Gude F; Forteza J; Puente-Domínguez JL
    Oncol Rep; 2007 May; 17(5):1109-14. PubMed ID: 17390052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometry in solid tumors: practical aspects and clinical applications.
    Dressler LG; Bartow SA
    Semin Diagn Pathol; 1989 Feb; 6(1):55-82. PubMed ID: 2645625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA analysis of in situ ductal carcinoma of the breast via flow cytometry.
    Ottesen GL; Christensen IJ; Larsen JK; Christiansen J; Hansen B; Andersen JA
    Cytometry; 1995 Sep; 22(3):168-76. PubMed ID: 8556947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures.
    Spyratos F; Briffod M
    Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].
    Chassevent A; Jourdan ML; Ferrero-Poüs M; Colonna M; Romain S; Spyratos F; Roth H; Bolla M
    Bull Cancer; 1999; 86(7-8):685-91. PubMed ID: 10477386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
    Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
    Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA index as prognostic factor in breast cancer.
    Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
    Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric S-phase fraction measurement in breast carcinoma: Influence of software and histogram resolution.
    Jourdan ML; Ferrero-Poüs M; Spyratos F; Romain S; Martin PM; Chassevent A
    Cytometry; 2002 Jun; 48(2):66-70. PubMed ID: 12116366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.